-+ 0.00%
-+ 0.00%
-+ 0.00%

INCANNEX HEALTHCARE COMPLETES PHASE 2 ENROLLMENT IN REPOSA PHASE 2/3 TRIAL OF IHL-42X, AN ORAL ONCE-DAILY TREATMENT FOR OBSTRUCTIVE SLEEP APNEA (OSA)

Reuters·04/03/2025 11:30:00

Please log in to view news